Does APIXABAN Cause Pulmonary toxicity? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Pulmonary toxicity have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
14
Reports of Pulmonary toxicity with APIXABAN
0.0%
of all APIXABAN reports
5
Deaths
12
Hospitalizations
How Dangerous Is Pulmonary toxicity From APIXABAN?
Of the 14 reports, 5 (35.7%) resulted in death, 12 (85.7%) required hospitalization, and 2 (14.3%) were considered life-threatening.
Is Pulmonary toxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Pulmonary toxicity?
AMIODARONE (886)
METHOTREXATE (811)
HYDROXYCHLOROQUINE (411)
RITUXIMAB (404)
TOCILIZUMAB (395)
LEFLUNOMIDE (364)
ABATACEPT (359)
ADALIMUMAB (326)
PEMBROLIZUMAB (318)
ETANERCEPT (291)
Which APIXABAN Alternatives Have Lower Pulmonary toxicity Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ